Contact
Please use this form to send email to PR contact of this press release:
Catalent and Minerva Neurosciences Enter Commercial Supply Agreement for Schizophrenia Drug Roluperidone
TO:
Please use this form to send email to PR contact of this press release:
Catalent and Minerva Neurosciences Enter Commercial Supply Agreement for Schizophrenia Drug Roluperidone
TO: